EP PerMed

EP PerMed: Towards a European Partnership in Personalised Medicine

The European Partnership for Personalised Medicine (EP PerMed) has been proposed in the framework of the EU’s 9th Framework Programme for Research and Innovation, Horizon Europe. Its aim is to align and promote regional and national priority setting and funding for research and implementation projects in the field of personalised medicine among the EU Member States, regions and associated countries as well as international partner countries.

European Partnerships will in Horizon Europe replace previous forms of partnerships, e.g. ERA-Nets or JPIs. Their general aim is to bring the European Commission and private and/or public partners together to address some of Europe’s most pressing challenges through concerted research and innovation initiatives. Identifying European Partnerships is an integral part of Horizon Europe’s strategic planning process. Under Horizon Europe partnerships are expected to establish formal and regular collaboration with other relevant research and innovation initiatives.

Over the last years, a great progress has been achieved in the field of personalised medicine by a large number of international, pan-European, national as well as regional activities and initiatives, including ERA PerMed. But to further develop and foster promising personalised medicine approaches, there is a need of an even closer collaboration and effort which could be achieved by such a European Partnership for Personalised Medicine under Horizon Europe.

ERA PerMed promotes the establishment of this European Partnership together with the closely connected to ICPerMed.

A draft concept paper and a guide for the candidate European Partnership for Personalised Medicine had been developed by ERA PerMed-ICPerMed. 

Further information will be provided during the EP PerMed Information Day that will be held virtually on 31st May 2021, registration is open!